| Financial Year |
March 31 2023 |
| Monetary Funds |
717,666,390.45 |
| Held-for-trading Financial Assets |
163,423,969.57 |
| Notes Receivable |
-- |
| Accounts Receivable |
213,391,052.52 |
| Advances to Suppliers |
9,659,832.92 |
| Other Receivables |
42,074,683.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
342,497,904.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
28,177,751.70 |
| Total Current Assets |
1,569,635,691.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
609,284,688.24 |
| Under-construction Projects |
151,912,437.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
108,146,976.32 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,968,187.02 |
| Deferred Income Tax Assets |
9,435,517.59 |
| Other Non-Current Assets |
10,642,890.33 |
| Sub-Total of Non-Current Assets |
1,005,813,089.52 |
| Total Assets |
2,575,448,780.87 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
147,839,907.73 |
| Accounts Payable |
174,294,590.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,842,509.88 |
| Taxes Payable |
10,845,346.25 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
39,710,603.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,463,453.95 |
| Other Current Liabilities |
297,328.29 |
| Sub-Total of Current Liabilities |
425,257,282.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,897,974.02 |
| Deferred Income Tax Liabilities |
11,042.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
47,049,151.55 |
| Total Liabilities |
472,306,434.14 |
| Paid-In Capital(Or Share Stock) |
70,101,402.00 |
| Capital Surplus |
1,322,651,504.58 |
| Surplus Reserve |
116,445,868.87 |
| LESS:Treasury Stock |
-4,126,595.45 |
| Undistributed Profits |
588,316,170.21 |
| Minority Stockholder's Interest |
1,042,915.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,102,099,430.99 |
| Owner's Equity（Stockholder's Equity） |
2,103,142,346.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,575,448,780.87 |
